Second malignancies in patients with essential thrombocythaemia

被引:10
|
作者
Randi, ML [1 ]
Fabris, F [1 ]
Girolami, A [1 ]
机构
[1] Univ Padua, Sch Med, Dept Med & Surg Sci, Padua, Italy
关键词
essential thrombocythaemia; hydroxyurea; secondary malignancies;
D O I
10.1111/j.1365-2141.2002.3346_1.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:923 / 923
页数:1
相关论文
共 50 条
  • [41] Urticarial Vasculitis Associated with Essential Thrombocythaemia
    Scott, Annabel D.
    Francis, Nicholas
    Yarranton, Helen
    Singh, Santa
    ACTA DERMATO-VENEREOLOGICA, 2014, 94 (02) : 244 - 245
  • [42] ANAGRELIDE IN THE TREATMENT OF ESSENTIAL THROMBOCYTHAEMIA (ET)
    Villa, M. R.
    Esposito, M.
    Improta, S.
    Onufrio, A.
    Mastrullo, L.
    HAEMATOLOGICA, 2012, 97 : 640 - 640
  • [43] Pharmacotherapy of essential thrombocythaemia: economic considerations
    Griesshammer, M
    Langer, C
    EXPERT OPINION ON PHARMACOTHERAPY, 2003, 4 (09) : 1499 - 1505
  • [44] Shared care protocol for the management of essential thrombocythaemia patients in primary care
    Sweeney, C.
    Roy, N. B. A.
    Mead, A.
    Wainscoat, J.
    Vyas, P.
    BRITISH JOURNAL OF HAEMATOLOGY, 2011, 153 : 55 - 55
  • [45] Increased procoagulant platelet-derived microparticles in patients with essential thrombocythaemia
    Cheung, BYY
    Parmar, K
    Daniel, Y
    Radia, D
    Hunt, BJ
    Harrison, CN
    BRITISH JOURNAL OF HAEMATOLOGY, 2006, 133 : 48 - 48
  • [46] A prenatal origin of childhood essential thrombocythaemia
    Langabeer, Stephen E.
    Haslam, Karl
    McMahon, Corrina
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 163 (05) : 676 - 678
  • [47] PRIAPISM AS THE FIRST MANIFESTATION OF ESSENTIAL THROMBOCYTHAEMIA
    Yilmaz, Muge
    Koseoglu, Fatos Dilan
    Ismailov, Fuat
    Hekimgil, Mine
    Saydam, Guray
    LEUKEMIA RESEARCH, 2017, 61 : S51 - S51
  • [48] Multiple aortic thrombi in essential thrombocythaemia
    Okada, Yosuke
    Kimura, Fumihiko
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 (05) : 862 - 862
  • [49] Risk of second primary malignancies in a population-based study of adult patients with essential thrombocythemia
    Shrestha, Rajesh
    Giri, Smith
    Pathak, Ranjan
    Bhatt, Vijaya Raj
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2016, 7 (04): : 324 - 330
  • [50] Use of pegylated interferon as second-line therapy in patients with essential thrombocythaemia or polycythaemia vera who are refractory or intolerant to other agents
    Rea, C. J.
    Radia, D. H.
    Cameron, L.
    Francis, Y.
    Harrison, C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2009, 145 : 66 - 66